fig1
![Metabolic features of tumor-derived extracellular vesicles: challenges and opportunities](https://image.oaes.cc/915b727a-acda-43f2-9ff2-69177e647256/evcna5012.fig.1.jpg)
Figure 1. Biomarkers of TDEVs described in four representative cancer types. Specific biomarkers (proteins, nucleic acids and metabolites) as well as general EV-related biomarkers have been included for breast, colorectal, pancreatic, and prostate cancers. Lipids: CE: cholesteryl esters; DAG: diacylglycerol; FA: fatty acids; GL: glycolipids; GP: glycerophospholipids. Glyco-PS: glycophosphosphingolipids; Lyso-PC: lysophospatidylcholine; P: propionate; PC: phosphatidylcholine; PE: phosphatidyletanolamine; PS: phosphatidylserine; SM: sphingomyelin; SP: sphingolipids; ST: sterols; TDEVs: tumor-derived extracellular vesicles.